Product Name: Human TNFRSF18 / GITR / CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR, Research Use)
Catalog Number: NBR-0693
Target Name: TNFRSF18 / GITR / CD357
Trade Name: Korea Natl.Cancer Ctr. patent anti-GITR
Antibody Drug Description: The drug is a recombinant fully human anti-GITR monoclonal antibody, being developed by Korea Natl.Cancer Ctr.. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: TNFRSF18
Synonyms: AITR; CD357; GITR
Target Description: Receptor for TNFSF18. Seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. Mediated NF-kappa-B activation via the TRAF2/NIK pathway.
Ensembl: ENSG00000186891 
Uniprot: Q9Y5U5